1. Home
  2. ALT vs RMR Comparison

ALT vs RMR Comparison

Compare ALT & RMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALT
  • RMR
  • Stock Information
  • Founded
  • ALT 1997
  • RMR 1986
  • Country
  • ALT United States
  • RMR United States
  • Employees
  • ALT N/A
  • RMR N/A
  • Industry
  • ALT Biotechnology: Pharmaceutical Preparations
  • RMR Professional Services
  • Sector
  • ALT Health Care
  • RMR Consumer Discretionary
  • Exchange
  • ALT Nasdaq
  • RMR Nasdaq
  • Market Cap
  • ALT 327.4M
  • RMR 290.8M
  • IPO Year
  • ALT N/A
  • RMR N/A
  • Fundamental
  • Price
  • ALT $3.59
  • RMR $17.37
  • Analyst Decision
  • ALT Strong Buy
  • RMR
  • Analyst Count
  • ALT 6
  • RMR 0
  • Target Price
  • ALT $17.40
  • RMR N/A
  • AVG Volume (30 Days)
  • ALT 2.4M
  • RMR 62.2K
  • Earning Date
  • ALT 11-11-2025
  • RMR 11-10-2025
  • Dividend Yield
  • ALT N/A
  • RMR 10.46%
  • EPS Growth
  • ALT N/A
  • RMR N/A
  • EPS
  • ALT N/A
  • RMR 1.12
  • Revenue
  • ALT $20,000.00
  • RMR $194,993,000.00
  • Revenue This Year
  • ALT N/A
  • RMR $323.25
  • Revenue Next Year
  • ALT $761,880.20
  • RMR $1.07
  • P/E Ratio
  • ALT N/A
  • RMR $15.32
  • Revenue Growth
  • ALT N/A
  • RMR 1.73
  • 52 Week Low
  • ALT $2.90
  • RMR $13.48
  • 52 Week High
  • ALT $11.16
  • RMR $26.06
  • Technical
  • Relative Strength Index (RSI)
  • ALT 45.32
  • RMR 60.13
  • Support Level
  • ALT $3.54
  • RMR $16.85
  • Resistance Level
  • ALT $3.72
  • RMR $17.10
  • Average True Range (ATR)
  • ALT 0.16
  • RMR 0.27
  • MACD
  • ALT 0.02
  • RMR 0.06
  • Stochastic Oscillator
  • ALT 21.87
  • RMR 100.00

About ALT Altimmune Inc.

Altimmune Inc is a clinical-stage biopharmaceutical company focused on developing treatments for obesity, metabolic diseases, and liver diseases. Its product candidate, pemvidutide (formerly known as ALT-801), is a novel, investigational, peptide-based GLP-1/glucagon dual receptor agonist. Pemvidutide is currently in clinical development for obesity and metabolic-associated steatohepatitis (MASH). The company also plans to pursue additional indications for pemvidutide that leverage the differentiated clinical profile of pemvidutide.

About RMR The RMR Group Inc.

The RMR Group Inc is a holding company that conducts its business through its subsidiary, which is an alternative asset management company that invests in real estate and manages real estate-related businesses. Its business consists of providing management services to publicly owned real estate investment trusts, or REITs, and real estate-related operating companies. It also provides management services to real estate securities mutual funds and commercial real estate finance companies. The company's operating segment is RMR LLC and All Other Operations. The RMR Group derives its revenue from providing business and property management services as well as advisory and other services.

Share on Social Networks: